Neos Therapeutics, Inc. (NEOS): Price and Financial Metrics

Neos Therapeutics, Inc. (NEOS)

Today's Latest Price: $0.57 USD

0.00 (-0.18%)

Updated Sep 25 4:00pm

Add NEOS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NEOS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -3.83 -- better than just 3% of US stocks.
  • NEOS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.96% of US stocks.
  • Neos Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 28.77%, greater than the shareholder yield of 90.27% of stocks in our set.
  • Stocks that are quantitatively similar to NEOS, based on their financial statements, market capitalization, and price volatility, are IO, DBD, TXMD, MNKD, and AQST.
  • NEOS's SEC filings can be seen here. And to visit Neos Therapeutics Inc's official web site, go to
NEOS Daily Price Range
NEOS 52-Week Price Range

NEOS Stock Price Chart Technical Analysis Charts

NEOS Price/Volume Stats

Current price $0.57 52-week high $1.98
Prev. close $0.57 52-week low $0.57
Day low $0.57 Volume 171,776
Day high $0.60 Avg. volume 210,168
50-day MA $0.69 Dividend yield N/A
200-day MA $0.99 Market Cap 28.36M

Neos Therapeutics, Inc. (NEOS) Company Bio

Neos Therapeutics develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The company was founded in 2008 and is based in Grand Prairie, Texas.

NEOS Latest News Stream

Event/Time News Detail
Loading, please wait...

NEOS Latest Social Stream

Loading social stream, please wait...

View Full NEOS Social Stream

Latest NEOS News From Around the Web

Below are the latest news stories about Neos Therapeutics Inc that investors may wish to consider to help them evaluate NEOS as an investment opportunity.

Neos Therapeutics to Present at Cantor Virtual Global Healthcare Conference

DALLAS and FORT WORTH, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, at 3:40 p.m. ET. A live webcast of the fireside chat will be available on the Investor Relations page of the company’s website at Following the presentation, a replay of the webcast will be available on Neos’ website for 30 days. About Neos Therapeutics Neos Therapeutics, Inc. (NASDAQ: NEOS) is a commercial-stage pharmaceutical company developing...

Yahoo | September 9, 2020

Neos Therapeutics EPS beats by $0.02, beats on revenue

Neos Therapeutics (NEOS): Q2 GAAP EPS of -$0.11 beats by $0.02.Revenue of $13.13M (-16.0% Y/Y) beats by $0.95M.Press Release...

Seeking Alpha | August 10, 2020

Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 2020

DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company…

GlobeNewswire | August 3, 2020

Neos Therapeutics Is Hitting A Considerable Air Pocket

Neos Therapeutics' (NEOS) share price has crashed as a result of the pandemic, but contrary to most other pharma companies, its share price hasn't recovered: The main reasons for the share price collapse are the pandemic and unusually low wholesale inventory levels, producing declines in subscriptions. However, both of these...

Shareholders Unite on Seeking Alpha | July 14, 2020

Here is What Hedge Funds Think About Neos Therapeutics Inc (NEOS)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

Yahoo | July 8, 2020

Read More 'NEOS' Stories Here

NEOS Price Returns

1-mo -15.90%
3-mo -16.79%
6-mo -24.00%
1-year -62.50%
3-year -93.45%
5-year -97.09%
YTD -62.25%
2019 -8.48%
2018 -83.82%
2017 74.36%
2016 -59.15%
2015 N/A

Continue Researching NEOS

Here are a few links from around the web to help you further your research on Neos Therapeutics Inc's stock as an investment opportunity:

Neos Therapeutics Inc (NEOS) Stock Price | Nasdaq
Neos Therapeutics Inc (NEOS) Stock Quote, History and News - Yahoo Finance
Neos Therapeutics Inc (NEOS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7534 seconds.